OTCM
MDLYF
Market cap463mUSD
, Last price
USD
Name
Medley Inc
Chart & performance
P/E
—
P/S
—
EPS
32.26
Vol. 1Y
—
Shs. 5Y
0.32%
Rev. 5Y
40.04%
Div Yld LY
—
Div Yld TTM
—
Revenues
36.79b
+25.54%
Net income
975m
-65.15%
CFO
3.49b
+42.46%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medley, Inc., a company based in Japan, develops and manages digital platforms for both the recruitment and medical industries. Its operations are structured into three primary segments: HR Platform Business, Medical Platform Business, and New Services. The firm's portfolio of offerings includes JobMedley, a human resources recruitment system specifically for medical, healthcare, and related sectors; CLINICS Telemedicine, a system enabling virtual consultations between patients and healthcare providers; CLINICS, a cloud-based platform for medical facility support; Pharms, which provides support systems for pharmacy front-desk operations; MEDLEY, a service offering medical information to patients; and Kaigo-no Honne, an online portal for searching nursing care facilities. Additionally, Medley, Inc. undertakes proof-of-concept testing for its Pharms solutions. The company was established in 2009 and maintains its corporate headquarters in Tokyo, Japan.
Key people
Kohei Takiguchi
President, Chief Executive Officer, Representative Director · since 2022
Ryo Kawahara
Chief Financial Officer, Senior Executive Officer, Senior Director of Finance, Director · since 2026
Makoto Takeuchi
Chief Human Resources Officer, Senior Executive Officer, Senior Director of Human Capital, Director · since 2025
Independent Director · since 2025
Independent Director · since 2025
Rina Sakuraba
Independent Director · since 2023
Independent Director · since 2025
Headquarters & legal address
六本木六丁目10番1号
東京都 港区 106-6113
JP
東京都 港区 106-6113
JP
Address
6-10-1, Roppongi
Minato-ku Tokyo 106-6113
JP
Minato-ku Tokyo 106-6113
JP
Other language
MEDLEY, INC.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||